The Low Temperature Plasma Surgery System market is segmented by application into ENT (ear, nose, and throat) surgeries, general surgery, and dermatological procedures. ENT surgeries dominate due to the widespread use of plasma ablation for tonsillectomies, adenoidectomies, and sinus treatments, leveraging the precision and reduced tissue trauma inherent to plasma technology. General surgery applications include soft tissue resection and hemostasis, where plasma systems offer advantages in minimizing thermal damage compared to traditional electrosurgery. Dermatological procedures represent a growing segment, driven by demand for non-invasive skin resurfacing and lesion removal. This Low Temperature Plasma Surgery System segmentation by application reflects clinical preferences and procedural adoption rates, directly influencing market growth trajectories.